Selecting Among Second-Step Antidepressant Medication Monotherapies | Zendy

A. John Rush | Zendy; Stephen R. Wisniewski | Zendy; Diane Warden | Zendy; James F. Luther | Zendy; Lori L. Davis | Zendy; Maurizio Fava | Zendy; Andrew A. Nierenberg | Zendy; Madhukar H. Trivedi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Selecting Among Second-Step Antidepressant Medication Monotherapies

Author(s) -

A. John Rush,

Stephen R. Wisniewski,

Diane Warden,

James F. Luther,

Lori L. Davis,

Maurizio Fava,

Andrew A. Nierenberg,

Madhukar H. Trivedi

Publication year - 2008

Publication title -

archives of general psychiatry

Language(s) - English

Resource type - Journals

eISSN - 1538-3636

pISSN - 0003-990X

DOI - 10.1001/archpsyc.65.8.870

Subject(s) - citalopram , sertraline , psychiatry , antidepressant , panic disorder , anxiety , psychology , bupropion , venlafaxine hydrochloride , depression (economics) , anxiety disorder , major depressive disorder , major depressive episode , medicine , venlafaxine , mood , macroeconomics , pathology , smoking cessation , economics

Little is known about selecting among second-step medications for major depressive disorder after intolerance or lack of remission with an initial selective serotonin reuptake inhibitor.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research